## Abstract ## BACKGROUND: Humoral‐mediated as well as cell‐mediated immunity is compromised in myeloma patients receiving treatment. Immunocompromised patients are at risk of developing herpes zoster. There is evidence from clinical trials that bortezomib therapy is associated with a significant
Comparative Trial of Acyclovir and Vidarabine in Disseminated Varicella-Zoster Virus Infections in Immunocompromised Patients
✍ Scribed by J. L. Vildé; F. Bricaire; C. Leport; M. Renaudie; F. Brun-Vézinet
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 438 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Adenine arabinoside monophosphate (ARA AMP) was used in ten immunosuppressed patients suffering from varicella or disseminated zoster, and compared to adenine arabinoside (vidarabine) in ten other similar patients. Good results were obtained with both drugs: the fever stopped suddenly in three or fo
To the Editor: I am puzzled by the comment of Gu¨rkan and Genc¸[1], in their description of a case of Bardet-Biedel syndrome, that a Philadelphia chromosome was detected. The Philadelphia chromosome is a derivative chromosome 22, resulting from a t(9;22)(q34;q11) translocation. This abnormality woul